HealthDiabetes Relief: Major Manufacturers Cap Insulin Prices at $35, Answering Calls for Affordability in the US Novo Nordisk, Sanofi, and Eli Lily are working together to make insulin less costly for millions of people in the US suffering from diabetes.by Quincy Jon
HealthCOVID-19 Vaccine: Sanofi, GSK Seeks Authorization, Says Immunization Shot is More Effective Against Severe Diseaseby Isaiah Richard
HealthCOVID-19 Vaccine Front-Runner Sanofi Indicted For Birth Defects Linked to Epilepsy Drugby Nhx T.
HealthCOVID-19 Vaccine Still on Phase 1 and Might Take 18 Months From Now to Create Says Global Health Officialby Jamie P.
HealthExperts Warn Dengue Vaccine Can Make People Sick: Here's What You Should Knowby Saranya Palanisamy
Healthy Living/WellnessFDA Approves Eli Lilly's Drug Basaglar For Diabetes Treatmentby Katrina Pascual
Healthy Living/WellnessSanofi Issues Voluntary Recall Of Epinephrine Injectors For Severe Allergyby Katherine Derla
Healthy Living/WellnessExpress Scripts Allots 750 Million To Cover Amgen And Sanofi Cholesterol Drugsby Rina Marie Doctor
Healthy Living/WellnessRegeneron And Sanofi Announce EU Approval For Anti-Cholesterol Drug Praluentby Dianne Depra
Business TechGoogle Teams Up With Sanofi To Improve Diabetes Management And Treatmentby Lauren Keating